Resource id #3DrugId:2d00000037resource(4) of type (mysql result) Drug Search

Main    A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    Main   

Drug ID: 2d00000037

Drug Name: Betaxolol Ophthalmic

Generic Names: Optipres -S | Nopres | Bexol Eye | Glucoptic (Eye) (5ml) | Ocupres -B | Ocubeta (Eye) (5ml) | Optipres | Iobet | Betapress (Eye) (5ml) | Bulol (Eye) | Betoptic | Betoptic S

Category: Antiglaucoma Agents

Legal Status: Non Opioid Prescription only drug


Indication for Mother: Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Recommended Dose: Ocular Hypertension; Open-angle glaucoma: As 0.25 or 0.5% soln: Instill 1 drop twice daily.

Recommended In: This medication is an ophthalmic beta-blocker, prescribed for glaucoma. It works by decreasing the pressure in the eye.

Directions For Use: It comes as eye drops to instill over affected eyes as directed by your physician.

Storage: Keep this medication in the container it came in and out of the reach of children.

Dosage Forms: Eye Drops

Side Effects: Eye - Photosensitivity, redness, itching sensation, inflammation, different pupil size, swelling, photophobia, blurred vision, foreign body sensation, dryness of the eyes, inflammation, discharge, pain, decreased visual acuity and crusty eyelashes.

Heart - Slow heart rate, heart block and heart failure.

Respiratory - Difficulty in breathing, asthma, thickened bronchial secretions and respiratory failure.

Central Nervous System - Sleeplessness, dizziness, unsteadiness, headache, depression, drowsiness and increase in signs and symptoms of myasthenia gravis.

Miscellaneous - Hives, toxic skin necrolysis, hair loss and inflammation of tongue.

In Case of Overdose: No information is available on overdosage of humans. A topical overdose of betaxolol hydrochloride ophthalmic suspension Ophthalmic Suspension 0.25% may be flushed from the eye(s) with warm tap water.

Avoid If: Contraindicated in patients with heart diseases/shock, asthma, severe chronic obstructive pulmonary disease (COPD) and hypersensitivity.

Caution should be exercised in patients with respiratory or breathing problems, heart failure, diabetes, asthma, overactive thyroid, low blood sugar levels, blood flow problems, any allergy, who are taking other medications, children, during pregnancy and breastfeeding.

It may cause drowsiness, dizziness or blurred vision, do not drive a car or operate machinery while taking this medication.

Avoid exposure to sunlight.

It may affect blood sugar level, monitor sugar level regularly.

Monitor eye pressure regularly while using this medication.

Drug Interaction: Oral Beta-Adrenergic Receptor Inhibitors

Patients who are receiving a beta-adrenergic receptor inhibitor orally and betaxolol hydrochloride ophthalmic suspension Ophthalmic Suspension 0.25% should be observed for a potential additive effect either on the intraocular pressure or on the known systemic effects of beta blockade.

Catecholamine-Depleting Drugs

Close observation of the patient is recommended when a beta-adrenergic receptor inhibitor is administered to patients receiving catecholamine-depleting drugs such as reserpine, because of possible additive effects and the production of hypotension and/or bradycardia which may result in vertigo, syncope, or postural hypotension.

Concomitant Adrenergic Psychotropic Drugs

Betaxolol is an adrenergic receptor inhibitor; therefore, caution should be exercised in patients using concomitant adrenergic psychotropic drugs.

Main    A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    Main